Earnings · US stocks

Ginkgo Bioworks Holdings, Inc. Class A (DNA) earnings

Ginkgo Bioworks Holdings, Inc. Class A published its quarterly report on 2026-11-05. The stock moved +20.58% in the 3 trading days after the report.

Report
quarterly report
Published
2026-11-05
Result
Bad / loss
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day+13.35%—
3 days+20.58%—
7 days-14.66%—

Report history

Over the last 8 reports, EPS beat the consensus estimate in 5 of them. The stock rose in the 3 trading days after 2 of 8 reports (average -10.85%).

PublishedEPSEPS surprise3 days after30 days after30d vs index
2026-11-05-0.48+10.35%+20.58%——
2026-08-05-0.73-4.66%-18.36%-16.33%-15.39%
2026-05-07-1.39-3.73%-19.19%-12.40%-14.15%
2026-02-26-0.77+30.50%-31.00%-33.57%-32.15%
2025-11-06-1.45-16.94%-25.13%-28.32%-29.85%
2025-08-07-1.10+29.79%-14.12%-15.53%-20.50%
2025-05-06-1.68+5.08%+20.31%+33.02%+26.11%
2025-02-25-1.21+6.65%-19.92%-44.02%-27.57%

The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.

Stock valuations: DNA

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.